Actemra Prices, Coupons and Patient Assistance Programs
Actemra (tocilizumab) is a member of the interleukin inhibitors drug class and is commonly used for Cytokine Release Syndrome, Giant Cell Arteritis, Juvenile Idiopathic Arthritis and others.
Actemra Prices
This Actemra price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Actemra intravenous solution (20 mg/mL) is around $476 for a supply of 4 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Intravenous Solution
| Quantity | Per unit | Price |
|---|---|---|
| 4 milliliters | $118.98 | $475.93 |
| 10 milliliters | $117.71 | $1,177.08 |
| 20 milliliters | $117.28 | $2,345.65 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Subcutaneous Solution
| Quantity | Per unit | Price |
|---|---|---|
| 0.9 milliliters | $1,185.99 | $1,067.39 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
Print NowThe free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Actemra Coupons and Rebates
Actemra offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Actemra Co-pay Card Program: Eligible Commercially Insured Patients - may pay $5 per prescription with savings of up to $15,000 calendar year; for additional information contact the program at 855-722-6729.
| Applies to: | Actemra |
| Number of uses: | 12 times within calendar year |
Patient Assistance Programs for Actemra
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: HealthWell Foundation Copay Program
Elligibility requirements:
- May have insurance
- Varies
- FDA Approved Diagnosis - See Program Website for Details
- The patient must also be residing in the US.
- This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
Applicable drugs:
- Actemra (tocilizumab)
Provider: Patient Access Network Foundation (PAN)
Elligibility requirements:
- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
- Actemra (tocilizumab)
Provider: Genentech Patient Foundation
Elligibility requirements:
- Uninsured or Underinsured with no prescription coverage for needed medication
- Income Guidelines published on Program Website
- Medically appropriate condition/diagnosis
- Must be treated by US licensed healthcare provider
- The Genentech Access to Care Foundation is now the Genentech Patient Foundation. Eligibility determined on a case-by-case basis. Call for most recent medications as the list is subject to change.
Applicable drugs:
- Actemra (tocilizumab)
Provider: Genentech Access Solutions (Actemra & Rituxan)
Elligibility requirements:
- Determined case by case
- Based on FPL
- Varies
- Must be treated by US licensed healthcare provider
Applicable drugs:
- Actemra (tocilizumab)
More about Actemra (tocilizumab)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Compare Alternatives
- Support Group
- En Español
- 24 Reviews
- Drug class: interleukin inhibitors
- FDA Approval History
Consumer resources
- Actemra
- Actemra (Tocilizumab Auto-Injectors)
- Actemra (Tocilizumab Prefilled Syringes)
- Actemra (Advanced Reading)
